Coverage
-
January 06, 2020
Teva Pharmaceuticals has agreed to pony up $54 million to resolve a False Claims Act case accusing it of using speaker events to bribe doctors to prescribe two of its drugs, attorneys for two whistleblowers who brought the suit announced Monday.
4 other articles on this case.
View all »